128 related articles for article (PubMed ID: 29202637)
1. Methods for Handling Unobserved Covariates in a Bayesian Update of a Cost-effectiveness Model.
Thorpe B; Carroll O; Sharples L
Med Decis Making; 2018 Feb; 38(2):150-162. PubMed ID: 29202637
[TBL] [Abstract][Full Text] [Related]
2. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Cooper NJ; Sutton AJ; Abrams KR
Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
4. Probabilistic cost-effectiveness analysis of HIV prevention. Comparing a Bayesian approach with traditional deterministic sensitivity analysis.
Johnson-Masotti AP; Laud PW; Hoffmann RG; Hayat MJ; Pinkerton SD
Eval Rev; 2001 Aug; 25(4):474-502. PubMed ID: 11480309
[TBL] [Abstract][Full Text] [Related]
5. A full Bayesian model to handle structural ones and missingness in economic evaluations from individual-level data.
Gabrio A; Mason AJ; Baio G
Stat Med; 2019 Apr; 38(8):1399-1420. PubMed ID: 30565727
[TBL] [Abstract][Full Text] [Related]
6. Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
[TBL] [Abstract][Full Text] [Related]
7. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
[TBL] [Abstract][Full Text] [Related]
8. Bayesian variable selection in cost-effectiveness analysis.
Negrín MA; Vázquez-Polo FJ; Martel M; Moreno E; Girón FJ
Int J Environ Res Public Health; 2010 Apr; 7(4):1577-96. PubMed ID: 20617047
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis.
Bounthavong M; Zargarzadeh A; Hsu DI; Vanness DJ
Value Health; 2011; 14(5):631-9. PubMed ID: 21839399
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.
Goodacre S; Sampson F; Stevenson M; Wailoo A; Sutton A; Thomas S; Locker T; Ryan A
Health Technol Assess; 2006 May; 10(15):1-168, iii-iv. PubMed ID: 16707072
[TBL] [Abstract][Full Text] [Related]
11. [Bayesian approach for the cost-effectiveness evaluation of healthcare technologies].
Berchialla P; Gregori D; Brunello F; Veltri A; Petrinco M; Pagano E
Epidemiol Prev; 2009; 33(3):123-8. PubMed ID: 19776461
[TBL] [Abstract][Full Text] [Related]
12. Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.
Jackson CH; Jit M; Sharples LD; De Angelis D
Med Decis Making; 2015 Feb; 35(2):148-61. PubMed ID: 23886677
[TBL] [Abstract][Full Text] [Related]
13. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.
Goodacre S; Thokala P; Carroll C; Stevens JW; Leaviss J; Al Khalaf M; Collinson P; Morris F; Evans P; Wang J
Health Technol Assess; 2013; 17(1):v-vi, 1-188. PubMed ID: 23331845
[TBL] [Abstract][Full Text] [Related]
14. One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.
McCabe C; Paulden M; Awotwe I; Sutton A; Hall P
Pharmacoeconomics; 2020 Feb; 38(2):135-141. PubMed ID: 31840216
[TBL] [Abstract][Full Text] [Related]
15. Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects.
Armero C; García-Donato G; López-Quílez A
Health Econ; 2010 Jun; 19(6):629-43. PubMed ID: 19424994
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
17. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
Hoomans T; Fenwick EA; Palmer S; Claxton K
Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
[TBL] [Abstract][Full Text] [Related]
19. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
